samedan logo
 
 
spacer
home > pmps > spring 2004 > achieve controlled release and increased bioavailability of pharmaceutical compounds through spray drying
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Achieve Controlled Release and Increased Bioavailability of Pharmaceutical Compounds Through Spray Drying

The recent interest in highly potent but poorly soluble pharmaceutical compounds has made controlled release and enhanced bioavailability of critical importance for many pharmaceutical dosage forms. This article describes spray drying techniques for manufacturing of products achieving controlled release and/or enhanced bioavailability. Four main categories of products are investigated, nano particles, microencapsulation, solid amorphous dispersions and dry emulsions.

Spray Drying

Spray drying is a very fast method of drying due to the large product surface area and high heat transfer coefficients available. The large surface area also allows for drying at a moderate to low temperature. These properties make spray drying feasible for heat sensitive materials. Rapid drying, and consequently fast stabilisation of feed material, makes spray drying ideally suited for encapsulation and producing dry emulsions or amorphous material. Particle engineering possibilities also include powder performance characteristics, such as aerodynamic particle size, geometric particle size, particle size distribution and powder flow properties.

Nano Particles

Spray drying of nano particles involves drying a suspension of nano particles in a suitable liquid, for example water. By spray drying, the primary particle size can be preserved and at the same time new desirable powder properties can be achieved. For example, powder with good flow properties and reduced tendency to produce air born dust or low aerodynamic particle size, combined with good powder flow properties.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
2
     

There are no comments in regards to this article.

spacer
By Henrik Schwartzbach, Pharma Division Process Technologist at Niro A/S

Henrik Schwartzbach joined Niro A/S in 1992, working in R&D and process optimisation. He has detailed and in-depth knowledge of cutting-edge pharmaceutical spray drying. As the Niro A/S Pharma Division Process Technologist, Henrik is deeply involved in setting the industry standards for pharmaceutical spray drying.
spacer
Henrik Schwartzbach
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

BioPharm America

15-17 September 2010, San Francisco, US

BioPharm America™ is where biotech industry partnerships get started. Meet one-to-one with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE™, the world’s leading partnering system for the life science industry, BioPharm America is the only event in North America based on the same proven formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®.
More info >>

 
News and Press Releases

PharmaBrand Summit 2010

Top pharmaceutical executives shared best practices at the PharmaBrand Summit 2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco and was organised by Marcus Evans
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement